Data From Pivotal Trial Published in the New England Journal of Medicine and Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition
Overall Response Rate, Duration of Response, Health-Related Quality of Life Secondary Endpoints Met; Overall Survival Continues to be Monitored Results to be Presented During an Oral Session at ASH on Sunday, December 7 at 12 p.m. PT Data to be Featured in ASH Press Briefing on Saturday, December 6 at 8 a.m. PT THOUSAND OAKS, Calif.
THE HAGUE , January 29, 2015 /PRNewswire/ -- Shell's (NYSE:RDS.A) (NYSE:RDS.B) CEO Ben van Beurden today updates on 2014 performance and his priorities for the company, in presentations to financial markets.
Sign-up for Capital Power and ENMAX Announce All Major Regulatory Approvals Received to Proceed With Genesee 4 & 5 Construction That Will Feature the Most Advanced Technology Available investment picks
Select Income REIT (NYSE: SIR) today issued the following statement
regarding a presentation filed by Lakewood Capital Management, LP in
connection with its proposal to nominate an individual for election to
the SIR Board of Trustees:
Select Income REIT is a real estate investment trust, or REIT, which
owns properties that are primarily net leased to single tenants.
Allianz Global Investors Fund Management LLC (the “Investment Manager")
announced today that Fund Cards, which contain statistical information
on the funds listed below as of December 31, 2014 are now available at http://us.allianzgi.com/Literature/Pages/ClosedEndFunds.aspx?ProductLineID=CEF&Level1=ulLiterature&Center=ulLiterature&Level2=liulLiteratureClosedEndFunds
The Investment Manager is an indirect, wholly-owned subsidiary of
Allianz Asset Management of America L.P., a member of Munich-based
78 Percent of Patients Treated With BLINCYTO Experienced a Complete Minimal Residual Disease (MRD) Response After One Treatment Cycle Results to be Presented During an Oral Session at the American Society of Hematology (ASH) 56th Annual Meeting and Exposition on Monday, December 8 at 10:30 a.m. PT
Data to be Featured in ASH Press Briefing on Saturday, December 6 at 10 a.m. PT THOUSAND OAKS, Calif.
Morgan Stanley announced today that its Global Stock Plan Services
(GSPS) group recently launched a new online stock plan portal, StockPlan
Connect, which will enable 1.5 million participants in over 150
countries to manage their equity compensation plans with ease.
OPKO Health, Inc. (NYSE:OPK) and Immuno Technologies, Inc. today
announced that the National Institutes of Health (NIH) has awarded a $3
million grant to develop a rapid diagnostic test for Lyme disease.
Pfizer Inc. (NYSE:PFE) today announced the publication of the detailed
results from PALOMA-1, a randomized Phase 2 study of palbociclib in
combination with letrozole versus letrozole alone, in The Lancet
Opus Bank (“Opus” or the “Bank”) (Nasdaq: OPB) announced today that it
has established and received regulatory approval for Opus Financial
Partners, LLC (“Opus Financial Partners” or “OFP”), the broker-dealer
subsidiary of the Bank.
While they acknowledge the challenges facing them, healthcare industry
leaders in the U.S. are less concerned about healthcare reform and
regulatory oversight than they were one year ago, according to a survey
conducted by GE Capital’s Healthcare Financial Services business.
The GEO Group (NYSE: GEO) (“GEO”) announced today the development
of a 626-bed expansion to the company-owned, 532-bed Karnes County
Residential Center in Texas under an amendment to GEO’s existing
contract with Karnes County, Texas and the existing intergovernmental
service agreement between Karnes County and U.S. Immigration and Customs
Sign-up for Five Oaks Investment Corp. Announces First Quarter 2015 Monthly Common Stock Dividend Rate of $0.125 Per Share for January, February and March 2015, and Preferred Stock Dividend investment picks
- Discuss interim results for Study 202 evaluating PEGPH20 with gemcitabine and ABRAXANE® in pancreatic cancer patients - - Review current clinical development plan to evaluate PEGPH20 in two Non-Small Cell Lung Cancer trials, in combination with chemotherapy and then with a PD-1 inhibitor -
- Provide 2015 financial guidance - SAN DIEGO , Jan.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.